Whole Slide Imaging Market Size
Imagine you're at the doctor's office, getting a biopsy. The doctor takes a small tissue sample and gives it to a lab to examine under a microscope. But instead of peering through a tiny lens, the lab uses a special scanner to create a digital copy of the entire slide, like a high-tech picture. This digital copy is called "whole slide imaging" (WSI). It's like having the slide right there on your computer screen, but better. Doctors can zoom in and see the tiniest details, getting a super-detailed view of the tissue. That means they can make more accurate diagnoses, catching diseases earlier. And it's not just one doctor looking at the slide. WSI lets multiple doctors from all over the world share the digital copy and work together to analyze it. That's especially important for complex diseases, like cancer. With more and more people being diagnosed with chronic diseases, WSI is becoming a must-have for doctors. It helps them detect and treat diseases sooner, which means better outcomes for patients and lower costs for healthcare.

The field of whole slide imaging is booming thanks to advances in imaging technology. We're talking high-res scanners, clever image analysis algorithms, and even AI lending a hand to medical imaging. Take the NanoZoomer S360MD, a system that Hamamatsu and Siemens Healthineers teamed up on in March 2023. This automated system lets pathologists create, zoom in on, and file digital images of surgical pathology slides made from tissue samples preserved in formalin and paraffin. It's a game-changer for pathologists, making it easier for them to review and interpret images. On top of that, the demand for precision medicine is driving up the use of surgical microscopes and video microscopes, which is opening up even more doors for growth in the whole slide imaging market.
Whole Slide Imaging Market Report Attributes
Report Attribute |
Details |
Base Year | 2022 |
---|
Whole Slide Imaging Market Size in 2022 | USD 602.7 Million |
---|
Forecast Period | 2023 to 2032 |
---|
Forecast Period 2023 to 2032 CAGR | 16.9% |
---|
2032 Value Projection | USD 2.9 Billion |
---|
Historical Data for | 2018 to 2022 |
---|
No. of Pages | 200 |
---|
Tables, Charts & Figures | 283 |
Segments covered | Type, Application, End-use, and Region |
---|
Growth Drivers | - Increasing demand for digital pathology solutions to enhance diagnostic accuracy
- Developments in whole slide imaging technology
- Increasing prevalence of chronic diseases
- Increasing drug discovery research activities
|
---|
Pitfalls & Challenges | - Stringent regulatory approvals
- Lack of reimbursement scenario
|
---|
COVID-19 Impact
The COVID-19 pandemic shook up the whole slide imaging market. At first, it was a tough time due to lockdowns and supply chain issues. But as the pandemic went on, pathology labs needed more equipment to keep up with all the research and development. This led to a surge in the demand for whole slide imaging technology. Why? People were more interested in remote pathology services, and technology was advancing quickly. Governments were also making changes to the rules, which made it easier for people to use whole slide imaging. For example, social distancing meant that people wanted to interact less in person. So, remote pathology services became more popular. With whole slide imaging, pathologists could check out and diagnose cases from afar, without having to be in the lab or hospital. This made the technology even more popular.
Whole Slide Imaging Market Trends
Exciting news in the medical field! Researchers are using digital pathology to transform the way they develop new drugs. Digital pathology involves scanning tissue samples and storing them on computers, allowing scientists to quickly analyze them and test their compatibility with potential treatments. This technology is a game-changer because it significantly speeds up the drug discovery process. Artificial intelligence and other advanced computer tools are also enhancing digital pathology, enabling researchers to identify patterns and predict how drugs will interact with the body. As a result, we can expect to see a surge in the use of slide imaging, making it easier and faster for scientists to find new cures and treatments. This is a major boost for healthcare and a promising sign for the future of medicine.
Additionally, increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and neurological disorders, often require detailed examination of tissue samples to make accurate diagnosis and determine appropriate treatment options. Pathologists use microscopy techniques to analyse these samples, and whole slide imaging offers an advanced digital alternative to traditional microscopy.
Whole Slide Imaging Market Analysis
Based on type, the whole slide imaging market is bifurcated into hardware, software, and services. Hardware is anticipated to account for a significant revenue approximately 248 million in 2022. Hardware typically includes slide scanners, which are specialized devices capable of capturing high-resolution images of whole slides. These scanners use various imaging technologies, such as brightfield, fluorescence, and confocal microscopy, to capture detailed images. The segment is projected to have a substantial expansion opportunity because of increasing number of product approvals and R&D activities.

The market for whole slide imaging is divided into different sections based on how it's used, like cancer, heart-related issues, thyroid issues, neurology, and others. The cancer part of the market grew the fastest, at 17.3% per year, during the time we looked at. Cancer is very common, and that's a big reason why the market for whole slide imaging is growing. For example, according to the American Cancer Society, cancer is the second leading cause of death in the U.S. after heart disease. In 2022, they said that about 1.9 million new cases of cancer would be found and that 609,360 people would die from cancer, which is about 1,670 deaths per day. Because cancer is becoming more common, the industry is growing, and healthcare groups, tech companies, and investors are putting money into it. This money helps pay for research into whole slide imaging technology, which has led to better images, better ways to analyze data, and ways to make the workflow better.
Imagine visiting the doctor feeling unwell. They collect a sample from you and send it to a special lab, called a diagnostic center. This lab has a remarkable device known as a whole slide imaging system. It's like a powerful scanner that creates digital images of your sample so doctors can examine them on computer screens. This is particularly beneficial for pathologists, who study samples like yours to unravel their mysteries. With whole slide imaging, pathologists don't need to wait for physical samples to arrive. They can access the digital images and begin their investigations immediately. It significantly speeds up the process of diagnosing your condition and providing the appropriate treatment. Moreover, it's more convenient for doctors and saves valuable time. This is why diagnostic centers embrace whole slide imaging. It enables them to diagnose patients faster, more accurately, and efficiently.

Human-like version Over the next decade, the U.S. whole slide imaging market is expected to reach $1.1 billion. It's been growing steadily, and this trend is likely to continue. The government is also helping to boost the industry. For example, the U.S. Department of Health & Human Services gave out $2.80 trillion last year to healthcare programs. Medicare and Medicaid got the biggest share of that money. Plus, the government has been making it easier for doctors to use whole slide imaging. These supportive policies are helping the industry grow even faster.
The U.S. Food and Drug Administration (FDA) granted clearance for certain whole slide imaging platforms for specific clinical uses, such as primary diagnosis. For instance, in October 2022, the NanoZoomer S360MD slide scanning system of Hamamatsu was given 510(k) approval by the Food and Drug Administration (FDA) to be marketed for primary diagnostic purpose. Such clearance has instilled confidence among healthcare providers and facilitated the adoption of digital pathology solutions such as whole slide imaging technology.
Whole Slide Imaging Market Share
Some of the notable key industry players operating in the whole slide imaging market include
- Hamamatsu Photonics K.K.
- Mikroscan Technologies, Inc.
- Leica Microsystems (Danaher Corporation)
- 3DHISTECH (Epredia)
- Koninklijke Philips N.V.
- Ventana Medical Systems Inc
- (Roche Holding AG)
- Nikon Corporation
- Indica Labs
- Inspirata
- Definiens (AstraZeneca)
- Autoscribe Informatics
- TECHNIDATA
- LabSmart Healthcare Technologies
- Xybion Digital Inc.
These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new type development and launches to strengthen type offerings as well as gain a competitive edge over others.
Whole Slide Imaging Industry News
- In March 2023, Agilent Technologies Inc. collaborated with Hamamatsu Photonics K.K., a leading supplier of whole slide imaging systems, to integrate their NanoZoomer, which includes the S360MD slide scanner system, into the Agilent digital pathology solution. Such strategies support the company’s expansion strategy as well as strengthens its overall customer base.
Whole slide imaging market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Type
- Hardware
- Software
- Services
By Application
- Cancer
- Cardiology
- Thyroid
- Neurology
- Others
By End-use
- Hospitals
- Diagnostic centers
- Others
The above information is provided for the following regions and countries
- North America
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Poland
- Switzerland
- Norway
- Finland
- Sweden
- Denmark
- The Netherlands
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Taiwan
- Indonesia
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Israel